Moscow/Sputnik: Over 117,000 doses of Russia's coronavirus vaccine Sputnik V have been already released into the market, and there are plans to produce over 2 million doses by the end of the year, Deputy Prime Minister Tatyana Golikova said on Tuesday.
In August, Sputnik V, developed by the Gamaleya research institute, became the world's first registered vaccine against COVID-19. It is now in phase III post-registration clinical trials.
"Since the moment of Sputnik V state registration, over 117,000 doses of the vaccine have been released into civil circulation. Producers plan to produce over 2 million doses by the year end. Currently, immunization of high-risk groups, doctors and teachers is prioritized," Golikova told the coordination council of human rights commissioners.
- Mali: WHO doctor seized by ‘unidentified assailants’, as UNHCR raises alarm over continuing violence
- North Korea imposes five-day lockdown in Pyongyang to battle rising cases of 'respiratory illness'
- China says 80% of its population have had Covid-19: Reports
- WHO calls for action to totally eliminate trans fat, ‘a toxic chemical that kills’
- $2.54 billion needed to tackle unprecedented health needs in 2023: WHO